Enovis ENOV Reconstructive — Cost of Goods Sold

Other segment segments

Similar metrics at other companies

IAR

IARTTissue Reconstruction — Cost of goods sold

$37.46M-24.0%

AIRRepair And Engineering — Cost of Goods Sold

$222.9M+28.6%

FCELProduct — Cost of Goods Sold

$20.28M+24.7%

PLUSProduct — Cost of Goods Sold

$362.87M+29.2%

AGYSProduct — Cost of Goods Sold

$6.17M+1.5%

INVAProduct — Cost of Goods Sold

$15.61M+76.5%

Questions, answered.

What is Enovis's reconstructive — cost of goods sold?

Enovis (ENOV) reported reconstructive — cost of goods sold of $97.34M in Q1 2026.

How has Enovis's reconstructive — cost of goods sold changed year-over-year?

Enovis's reconstructive — cost of goods sold increased by 0.1% year-over-year, from $97.28M to $97.34M.

What is the long-term trend for Enovis's reconstructive — cost of goods sold?

Over 3 years (2022 to 2025), Enovis's reconstructive — cost of goods sold has grown at a 28.8% compound annual growth rate (CAGR), from $171.63M to $366.37M.

What does reconstructive — cost of goods sold mean?

The direct costs associated with manufacturing, sourcing, and delivering the reconstructive medical products and services sold during the period. Monitoring this metric is essential for evaluating the segment's production efficiency and gross margin performance.